(Total Views: 114)
Posted On: 04/11/2022 10:45:52 AM
Post# of 89355

$MNOV News Article - MediciNova Announces Plans for a Phase 2 Trial of MN-001 (tipelukast) in NAFLD with Type 2 Diabetes Mellitus and Hypertriglyceridemia https://marketwirenews.com/news-releases/medi...99050.html


My Twitter: WhyteStocks